WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AGIO

Based on 7 analysts offering 12 month price targets for Agios Pharmaceuticals Inc

Min Forecast
$32.00+13.72%
Avg Forecast
$40.14+42.65%
Max Forecast
$50.00+77.68%

Should I buy or sell AGIO stock?

Based on 7 analysts offering ratings for Agios Pharmaceuticals Inc.

Buy
Strong Buy
3 analysts 42.86%
Buy
2 analysts 28.57%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although AGIO's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates AGIO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their AGIO stock forecasts and price targets.

AGIO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-30
lockedlocked$00.00+00.00%2026-04-21
lockedlocked$00.00+00.00%2026-04-20
lockedlocked$00.00+00.00%2026-04-06
lockedlocked$00.00+00.00%2026-04-01
Citigroup
Top 28%
73
Strong BuyMaintains$46.00+59.78%2026-03-05
Leerink Partners
Bottom 4%
4
BuyMaintains$40.00+38.94%2025-12-26

1 of 1

Forecast return on equity

Is AGIO forecast to generate an efficient return?

Company
-13.12%
Industry
85.8%
Market
169.74%
AGIO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AGIO forecast to generate an efficient return on assets?

Company
-12.28%
Industry
29.42%
AGIO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AGIO earnings per share forecast

What is AGIO's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
-$6.30
Avg 2 year Forecast
-$4.98
Avg 3 year Forecast
-$3.43

AGIO revenue forecast

What is AGIO's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$127.2M+92.65%
Avg 2 year Forecast
$266.2M+303.06%
Avg 3 year Forecast
$406.8M+515.95%
AGIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AGIO revenue growth forecast

How is AGIO forecast to perform vs Biotechnology companies and vs the US market?

Company
83.26%
Industry
36.05%
Market
13.75%
AGIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AGIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AGIO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AGIO$28.79$40.14+39.43%Buy
CAPR$29.58$57.00+92.70%Strong Buy
NTLA$12.37$22.15+79.09%Buy
NUVB$4.79$13.20+175.57%Buy
SNDX$19.77$105.44+433.35%Strong Buy
View Top Biotech Stocks

Agios Pharmaceuticals Stock Forecast FAQ

Is Agios Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: AGIO) stock is to Buy AGIO stock.

Out of 7 analysts, 3 (42.86%) are recommending AGIO as a Strong Buy, 2 (28.57%) are recommending AGIO as a Buy, 2 (28.57%) are recommending AGIO as a Hold, 0 (0%) are recommending AGIO as a Sell, and 0 (0%) are recommending AGIO as a Strong Sell.

If you're new to stock investing, here's how to buy Agios Pharmaceuticals stock.

What is AGIO's earnings growth forecast for 2026-2028?

(NASDAQ: AGIO) Agios Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.38%.

Agios Pharmaceuticals's earnings in 2026 is -$422,603,000.On average, 12 Wall Street analysts forecast AGIO's earnings for 2026 to be -$374,409,462, with the lowest AGIO earnings forecast at -$416,075,271, and the highest AGIO earnings forecast at -$343,448,542. On average, 12 Wall Street analysts forecast AGIO's earnings for 2027 to be -$296,239,979, with the lowest AGIO earnings forecast at -$363,799,727, and the highest AGIO earnings forecast at -$237,291,720.

In 2028, AGIO is forecast to generate -$203,719,997 in earnings, with the lowest earnings forecast at -$280,337,271 and the highest earnings forecast at -$87,423,265.

What is AGIO's revenue growth forecast for 2026-2028?

(NASDAQ: AGIO) Agios Pharmaceuticals's forecast annual revenue growth rate of 83.26% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.05%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Agios Pharmaceuticals's revenue in 2026 is $66,048,000.On average, 12 Wall Street analysts forecast AGIO's revenue for 2026 to be $7,567,167,529, with the lowest AGIO revenue forecast at $5,187,113,737, and the highest AGIO revenue forecast at $10,344,491,669. On average, 12 Wall Street analysts forecast AGIO's revenue for 2027 to be $15,831,937,032, with the lowest AGIO revenue forecast at $7,594,524,469, and the highest AGIO revenue forecast at $22,492,757,240.

In 2028, AGIO is forecast to generate $24,194,239,973 in revenue, with the lowest revenue forecast at $16,907,778,439 and the highest revenue forecast at $30,723,033,209.

What is AGIO's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: AGIO) forecast ROA is -12.28%, which is lower than the forecast US Biotechnology industry average of 29.42%.

What is AGIO's Price Target?

According to 7 Wall Street analysts that have issued a 1 year AGIO price target, the average AGIO price target is $40.14, with the highest AGIO stock price forecast at $50.00 and the lowest AGIO stock price forecast at $32.00.

On average, Wall Street analysts predict that Agios Pharmaceuticals's share price could reach $40.14 by Apr 30, 2027. The average Agios Pharmaceuticals stock price prediction forecasts a potential upside of 39.43% from the current AGIO share price of $28.79.

What is AGIO's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AGIO) Agios Pharmaceuticals's current Earnings Per Share (EPS) is -$7.25. On average, analysts forecast that AGIO's EPS will be -$6.30 for 2026, with the lowest EPS forecast at -$7.00, and the highest EPS forecast at -$5.78. On average, analysts forecast that AGIO's EPS will be -$4.98 for 2027, with the lowest EPS forecast at -$6.12, and the highest EPS forecast at -$3.99. In 2028, AGIO's EPS is forecast to hit -$3.43 (min: -$4.71, max: -$1.47).

What is AGIO's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: AGIO) forecast ROE is -13.12%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.